Titre : Méticilline

Méticilline : Questions médicales fréquentes

Termes MeSH sélectionnés :

Complement C3
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Méticilline : Questions médicales les plus fréquentes", "headline": "Méticilline : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Méticilline : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-11", "dateModified": "2025-04-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Méticilline" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Pénicillines", "url": "https://questionsmedicales.fr/mesh/D010406", "about": { "@type": "MedicalCondition", "name": "Pénicillines", "code": { "@type": "MedicalCode", "code": "D010406", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.300.750" } } }, "about": { "@type": "MedicalCondition", "name": "Méticilline", "alternateName": "Methicillin", "code": { "@type": "MedicalCode", "code": "D008712", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Carmen Torres", "url": "https://questionsmedicales.fr/author/Carmen%20Torres", "affiliation": { "@type": "Organization", "name": "Area de Bioquímica y Biología Molecular, Universidad de La Rioja, Logroño, Spain." } }, { "@type": "Person", "name": "Eric S Donkor", "url": "https://questionsmedicales.fr/author/Eric%20S%20Donkor", "affiliation": { "@type": "Organization", "name": "1 Department of Medical Microbiology, University of Ghana, Accra, Ghana." } }, { "@type": "Person", "name": "Patrick Butaye", "url": "https://questionsmedicales.fr/author/Patrick%20Butaye", "affiliation": { "@type": "Organization", "name": "School of Veterinary Medicine, Ross University, West Farm 000265, Saint Kitts and Nevis." } }, { "@type": "Person", "name": "Assia Mairi", "url": "https://questionsmedicales.fr/author/Assia%20Mairi", "affiliation": { "@type": "Organization", "name": "Laboratoire d'Ecologie Microbienne, FSNV, Université de Bejaia, Bejaia 06000, Algeria." } }, { "@type": "Person", "name": "Abdelaziz Touati", "url": "https://questionsmedicales.fr/author/Abdelaziz%20Touati", "affiliation": { "@type": "Organization", "name": "Laboratoire d'Ecologie Microbienne, FSNV, Université de Bejaia, Bejaia 06000, Algeria." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Plasma complement C3 and C3a are increased in major depressive disorder independent of childhood trauma.", "datePublished": "2022-11-29", "url": "https://questionsmedicales.fr/article/36447174", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-022-04410-3" } }, { "@type": "ScholarlyArticle", "name": "Complement gene mutations in children with C3 glomerulopathy: do they affect the response to mycophenolate mofetil?", "datePublished": "2023-12-02", "url": "https://questionsmedicales.fr/article/38041748", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00467-023-06231-2" } }, { "@type": "ScholarlyArticle", "name": "Changes in serum TIM-3 and complement C3 expression in workers due to Mn exposure.", "datePublished": "2023-11-09", "url": "https://questionsmedicales.fr/article/38026392", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2023.1289838" } }, { "@type": "ScholarlyArticle", "name": "Complement C3 as a potential drug target in periodontitis: Evidence from the cis-Mendelian randomization approach.", "datePublished": "2023-11-05", "url": "https://questionsmedicales.fr/article/37926509", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jcpe.13894" } }, { "@type": "ScholarlyArticle", "name": "Microglia refine developing retinal astrocytic and vascular networks through the complement C3/C3aR axis.", "datePublished": "2023-03-01", "url": "https://questionsmedicales.fr/article/36762625", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1242/dev.201047" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "bêta-Lactames", "item": "https://questionsmedicales.fr/mesh/D047090" }, { "@type": "ListItem", "position": 6, "name": "Pénicillines", "item": "https://questionsmedicales.fr/mesh/D010406" }, { "@type": "ListItem", "position": 7, "name": "Méticilline", "item": "https://questionsmedicales.fr/mesh/D008712" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Méticilline - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Méticilline", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Méticilline", "description": "Comment diagnostiquer une infection résistante à la méticilline ?\nQuels tests sont utilisés pour détecter la résistance à la méticilline ?\nQuels symptômes indiquent une infection à staphylocoque ?\nQuand faut-il suspecter une infection à SARM ?\nQuel rôle joue la culture de sang dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Méticilline", "description": "Quels sont les symptômes d'une infection à SARM ?\nComment se manifeste une infection cutanée ?\nQuels signes indiquent une infection systémique ?\nLes infections à méticilline provoquent-elles des douleurs ?\nQuels symptômes nécessitent une consultation urgente ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Méticilline", "description": "Comment prévenir les infections à SARM ?\nLes antibiotiques préventifs sont-ils efficaces ?\nQuel rôle joue la vaccination dans la prévention ?\nComment éviter la propagation en milieu hospitalier ?\nLes soins des plaies aident-ils à prévenir les infections ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Méticilline", "description": "Quel est le traitement principal des infections à SARM ?\nComment traiter une infection cutanée causée par SARM ?\nLes antibiotiques oraux sont-ils efficaces contre SARM ?\nQuelle est l'importance de l'antibiogramme ?\nPeut-on utiliser la méticilline pour traiter le SARM ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Méticilline", "description": "Quelles sont les complications possibles d'une infection à SARM ?\nComment une infection à SARM peut-elle affecter le cœur ?\nLes infections à SARM peuvent-elles causer des lésions pulmonaires ?\nQuels risques pour les patients diabétiques ?\nLes infections à SARM peuvent-elles être fatales ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Méticilline", "description": "Quels sont les principaux facteurs de risque pour SARM ?\nLe partage d'objets personnels augmente-t-il le risque ?\nLes athlètes sont-ils plus à risque d'infection à SARM ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes patients en soins intensifs sont-ils à risque ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Complement+C3&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection résistante à la méticilline ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des cultures bactériennes et des tests de sensibilité aux antibiotiques sont effectués." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter la résistance à la méticilline ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Le test de diffusion sur gélose et le test d'agar de dilution sont couramment utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection à staphylocoque ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, rougeur, gonflement et douleur au site d'infection sont des signes courants." } }, { "@type": "Question", "name": "Quand faut-il suspecter une infection à SARM ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "En cas d'infections cutanées récurrentes ou de non-réponse aux antibiotiques classiques." } }, { "@type": "Question", "name": "Quel rôle joue la culture de sang dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'identifier la présence de bactéries dans le sang et leur sensibilité." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection à SARM ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des rougeurs, des douleurs, des abcès et parfois de la fièvre." } }, { "@type": "Question", "name": "Comment se manifeste une infection cutanée ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des rougeurs, des gonflements, de la chaleur et des douleurs." } }, { "@type": "Question", "name": "Quels signes indiquent une infection systémique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, frissons, fatigue extrême et confusion peuvent indiquer une infection grave." } }, { "@type": "Question", "name": "Les infections à méticilline provoquent-elles des douleurs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections peuvent causer des douleurs localisées ou généralisées selon la gravité." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une consultation urgente ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme une fièvre élevée, des difficultés respiratoires ou des éruptions cutanées graves." } }, { "@type": "Question", "name": "Comment prévenir les infections à SARM ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Pratiquer une bonne hygiène, se laver les mains et éviter le partage d'objets personnels." } }, { "@type": "Question", "name": "Les antibiotiques préventifs sont-ils efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation d'antibiotiques préventifs n'est généralement pas recommandée sans indication." } }, { "@type": "Question", "name": "Quel rôle joue la vaccination dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccin spécifique contre le SARM, mais la vaccination générale aide." } }, { "@type": "Question", "name": "Comment éviter la propagation en milieu hospitalier ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des protocoles stricts d'hygiène et d'isolement des patients infectés sont essentiels." } }, { "@type": "Question", "name": "Les soins des plaies aident-ils à prévenir les infections ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon soin des plaies réduit le risque d'infection par des bactéries résistantes." } }, { "@type": "Question", "name": "Quel est le traitement principal des infections à SARM ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les infections à SARM sont généralement traitées avec des antibiotiques comme la vancomycine." } }, { "@type": "Question", "name": "Comment traiter une infection cutanée causée par SARM ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des antibiotiques et parfois un drainage chirurgical des abcès." } }, { "@type": "Question", "name": "Les antibiotiques oraux sont-ils efficaces contre SARM ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains antibiotiques oraux comme la clindamycine peuvent être efficaces selon la sensibilité." } }, { "@type": "Question", "name": "Quelle est l'importance de l'antibiogramme ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'antibiogramme détermine la sensibilité des bactéries aux antibiotiques, guidant le traitement." } }, { "@type": "Question", "name": "Peut-on utiliser la méticilline pour traiter le SARM ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, le SARM est résistant à la méticilline et nécessite d'autres antibiotiques." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une infection à SARM ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections profondes, des septicémies et des infections osseuses." } }, { "@type": "Question", "name": "Comment une infection à SARM peut-elle affecter le cœur ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une endocardite, une infection des valves cardiaques, potentiellement mortelle." } }, { "@type": "Question", "name": "Les infections à SARM peuvent-elles causer des lésions pulmonaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des pneumonies, surtout chez les patients immunodéprimés." } }, { "@type": "Question", "name": "Quels risques pour les patients diabétiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les patients diabétiques sont plus susceptibles de développer des infections graves à SARM." } }, { "@type": "Question", "name": "Les infections à SARM peuvent-elles être fatales ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être mortelles, surtout si elles ne sont pas traitées rapidement et correctement." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour SARM ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hospitalisation, les interventions chirurgicales et l'immunodépression." } }, { "@type": "Question", "name": "Le partage d'objets personnels augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le partage d'objets comme les serviettes ou les rasoirs peut favoriser la transmission." } }, { "@type": "Question", "name": "Les athlètes sont-ils plus à risque d'infection à SARM ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en raison des contacts physiques fréquents et des blessures cutanées potentielles." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles ont un système immunitaire affaibli, ce qui augmente le risque d'infections." } }, { "@type": "Question", "name": "Les patients en soins intensifs sont-ils à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en raison de leur état de santé fragile et de l'exposition à des bactéries résistantes." } } ] } ] }

Sources (1986 au total)

Plasma complement C3 and C3a are increased in major depressive disorder independent of childhood trauma.

Dysregulated complement system is linked to pathophysiology of major depressive disorder (MDD). Childhood trauma has been associated with an increased incidence of adult depression via a putative mech... The participants were 49 medication-free MDD patients and 45 healthy controls. All participants were asked to finish the Childhood Trauma Questionnaire, followed by blood sampling for measurement of p... Peripheral plasma concentration of C3 and C3a in medication-free MDD group was significantly higher than that in the healthy controls; whereas the concentration of plasma C1q and CRP in depressed pati... Our data suggest that complement C3 and C3a may be implicated in the pathophysiology of MDD, although traumatic childhood experiences were not associated with the circulating levels of complement C3, ...

Complement gene mutations in children with C3 glomerulopathy: do they affect the response to mycophenolate mofetil?

C3 glomerulopathy (C3G) is a complement-mediated disease. Although genetic studies are not required for diagnosis, they are valuable for treatment planning and prognosis prediction. The aim of this st... Sixty pediatric C3G patients were included, divided into two groups based on complement-related gene mutations. Demographic and clinical-pathological findings, treatment modalities, and outcome data w... Out of the 60 patients, 17 had mutations. The most common mutation was in the CFH gene (47%). The mean age at diagnosis was higher in the group with mutation (12.9 ± 3.6 vs. 11.2 ± 4.1 years, p = 0.03... This study is the largest pediatric C3G study examining the relationship between genotype and phenotype. We showed that the mutation group often presented with asymptomatic urinary abnormalities, was ...

Complement C3 as a potential drug target in periodontitis: Evidence from the cis-Mendelian randomization approach.

Evidence from a Phase IIa trial showed that a complement C3-targeted drug reduced gingival inflammation in patients with gingivitis. Using drug-target Mendelian randomization (MR), we investigated whe... We used multiple 'cis' instruments from the vicinity of the encoding loci of C3. Instrument selection was restricted to the drug target encoding loci (chromosome 19; 6,677,715-6,730,573 (GRCh37/hg19))... MR analysis revealed that the inhibition of C3 reduces the odds of periodontitis (OR 0.91 per 1 standard deviation reduction in C3; 95% confidence interval 0.87-0.96, p value = .0003).... Findings from our MR analysis suggest a potential protective effect of C3 blockade against periodontitis....

Serum C3 complement levels predict prognosis and monitor disease activity in Guillain-Barré syndrome.

Biomarkers are needed to predict prognosis and disease activity in patients with Guillain-Barré syndrome (GBS). The complement system is a key player in the pathogenesis of GBS. This study aimed to as... We reviewed the medical records of 76 GBS patients with C3 and C4 measurements during hospitalization between 2010 and 2021. Clinical outcomes were correlated with baseline serum C3, C4, and seven add... Higher C3, but not C4, was associated with poorer outcomes: lower Medical Research Council sum scores (MRCSS), higher GBS disability score (GBSDS), longer hospitalization, and more frequent treatment-... This study highlights the use of serum C3 as a novel mechanistic biomarker in GBS. Larger prospective studies are needed to validate our findings....

Relationship Between Serum Complement C3 Levels and Outcomes Among Patients With Anti-GBM Disease.

IgG and complement 3 (C3) are generally found to be deposited along the glomerular basement membrane (GBM) in human anti-GBM disease. The pathogenic role of complement activation in kidney damage of a... Ninety-four anti-GBM disease patients between January 2004 and December 2020 at the National Clinical Research Center of Kidney Diseases Jinling Hospital were retrospectively analyzed, and were divide... A total of 94 patients (aged 43.6 ± 16.2; male patients, 46%) with anti-GBM disease were enrolled. There were 26 patients with low C3 levels and 68 patients with normal C3 levels. Compared with the no... The kidney outcomes of anti-GBM disease in the low C3 group were poorer than those in the normal C3 group. The influence of C3 on the kidney outcomes of patients with anti-GBM disease may be of clinic...

Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis.

The activation of the complement system contributes essentially to the pathogenesis of anti-neutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis. We here aimed to directly compare levels... Serum levels of complement components C3 and C4 were directly compared in association with clinical and outcome data in a retrospective cohort of ANCA-associated renal vasculitis.... As compared to poor outcome prediction by low levels of complement C3 (p = 0.0093), low levels of complement C4 did not associate with early requirement of kidney replacement therapy (KRT) or death (p... While low levels of complement C3 were superior in predicting poor outcome in ANCA-associated renal vasculitis, a minor fraction with poor outcome had isolated C4 lowering not captured by serum C3 mea...

Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity.

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a potentially life-threatening systemic small-vessel vasculitis that is characterized by pauci-immune glomerulonephritis, depi... A cohort of 53 biopsy-proven cases of ANCA-associated renal vasculitis were retrospectively enrolled in a single-center observational study. Univariate and multivariate regression analysis was perform... Lower platelet counts correlated with markers of kidney injury including eGFR loss (... Based on our observation that an association between platelets and complement system activation is only observed in the MPO-ANCA subgroup, this could implicate that platelets and complement C3 link in...